Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?

Reprod Biol Endocrinol · 2021 · PMC8655989 · PMID 34886872

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significancep = 0.3not close (p > 0.1)

The pregnancy rate per fresh transfer was higher among the HP-hMG treatment cycles (4/14, 29%) compared with the rFSH+rLH cycles (2/14, 15%), although this difference did not reach statistical significance ( p = 0.3).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.